Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
The active component in Victoza, liraglutide, has also demonstrated efficacy for weight loss
Mounjaro and Zepbound are indicated only for adult use in patients 18 years of age and older
Use of metformin, in particular, during pregnancy could lead to nutrient restriction to the fetus, and this has become a large focus of research
Patients Struggling with Weight Loss Yurpeak is also approved for chronic weight management in adults with: BMI 30 kg/m (Obesity) BMI 27 kg/m with conditions such as diabetes, hypertension, fatty liver, or sleep apnea When combined with proper nutrition and exercise, patients often achieve substantial and sustained weight loss
Both drugs have been shown to have cardiovascular benefits, reducing the risk of major adverse cardiovascular events in people with type 2 diabetes
